Lipid accumulation levels reveal hidden osteoporosis risk

	Muscular Dystrophy
	The latest muscular dystrophy news from News Medical

Researchers investigate the use of lipid accumulation products as a predictor of osteoporosis.

			Existing therapies may help control chronic muscle inflammation in Duchenne muscular dystrophy A new study led by researchers at Hospital for Special Surgery (HSS) suggests that currently available therapies may help control chronic muscle inflammation in Duchenne muscular dystrophy (DMD), a severe condition that leads to muscle weakness and premature death.

			AAN releases Evidence in Focus Article on new gene therapy for Duchenne muscular dystrophy To help neurologists, clinicians and families understand the current evidence for a new gene therapy for Duchenne muscular dystrophy called delandistrogene moxeparvovec, the American Academy of Neurology (AAN) has issued an Evidence in Focus article, published May 14, 2025, online in Neurology.

	Antimalarial drug enhances effect of aminoglycosides in genetic disorders The antimalarial drug mefloquine could help treat genetic diseases such as cystic fibrosis, Duchenne muscular dystrophy, as well as some cancers.

	New app connects dentists to patients' medical histories Most dental offices are independent practices and often don't have access to a patient's medical history. For providing dental care, it is critical that dentists have up-to-date medical and medication histories of their patients to reduce risk during procedures and ensure the success of the treatment.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2025